Sepsis-Associated Outcomes in Critically Ill Patients with Malignancies
Viviane BL Torres(Universidade Federal do Rio de Janeiro), Márcio Soares(University of Copenhagen), Pedro Caruso, Eliézer Silva(Erasmus Hospital), Ulysses V. A. Silva(Università Cattolica del Sacro Cuore), Jorge I. Salluh(Universidade Federal do Rio de Janeiro), Fernando A. Bozza(D’Or Institute for Research and Education), Frederico Bruzzi de Carvalho(Mater Dei Hospital), Paulo C. de Paula Souza(Hospital Universitário Antônio Pedro), Michele MG Godoy(Hospital das Clínicas da Universidade Federal de Pernambuco), Arthur Vianna, Luciano C. P. Azevedo(Hospital Israelita Albert Einstein), Nelson Spector(Universidade Federal do Rio de Janeiro), José RA Azevedo(Hospital São Domingos), André P. Torelly(Hospital de Base)
Cited by 92
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527
A Central Role for Free Heme in the Pathogenesis of Severe Sepsis
|Science Translational Medicine|2010|492